Procypra Therapeutics is managed by Dr. Sean Lumb, managing director of the company, responsible for Procypra’s business development activities and day-to-day operations.
Sean has over 13 years experience in early stage technology commercialization and drug development, having worked in intellectual property commercialization at the University of Melbourne and the University of British Columbia. Over this period Sean has led or been involved in the creation, financing and management of six university start-up companies since 2000.
Sean completed his honours BSc in chemistry at Queen’s University at Kingston and his PhD in chemistry at the University of British Columbia in Vancouver, Canada.